361 related articles for article (PubMed ID: 17893859)
1. High-performance proteomics as a tool in biomarker discovery.
Meyer HE; Stühler K
Proteomics; 2007 Sep; 7 Suppl 1():18-26. PubMed ID: 17893859
[TBL] [Abstract][Full Text] [Related]
2. Global and targeted quantitative proteomics for biomarker discovery.
Veenstra TD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
[TBL] [Abstract][Full Text] [Related]
3. Urinary proteomics--a tool for biomarker discovery.
Pejcic M; Stojnev S; Stefanovic V
Ren Fail; 2010 Jan; 32(2):259-68. PubMed ID: 20199189
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective.
Alvarez-Llamas G; de la Cuesta F; Barderas ME; Darde V; Padial LR; Vivanco F
Expert Rev Proteomics; 2008 Oct; 5(5):679-91. PubMed ID: 18937558
[TBL] [Abstract][Full Text] [Related]
5. Proteomics methods and applications for the practicing clinician.
Reisdorph NA; Reisdorph R; Bowler R; Broccardo C
Ann Allergy Asthma Immunol; 2009 Jun; 102(6):523-9. PubMed ID: 19558013
[TBL] [Abstract][Full Text] [Related]
6. Proteomics as a tool for the modelling of biological processes and biomarker development in nutrition research.
de Roos B; McArdle HJ
Br J Nutr; 2008 Jun; 99 Suppl 3():S66-71. PubMed ID: 18598591
[TBL] [Abstract][Full Text] [Related]
7. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J
J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325
[TBL] [Abstract][Full Text] [Related]
8. Proteomic approaches in biological and medical sciences: principles and applications.
Conrotto P; Souchelnytskyi S
Exp Oncol; 2008 Sep; 30(3):171-80. PubMed ID: 18806738
[TBL] [Abstract][Full Text] [Related]
9. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
Ekegren T; Hanrieder J; Bergquist J
J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
[TBL] [Abstract][Full Text] [Related]
10. Introducing the CPL/MUW proteome database: interpretation of human liver and liver cancer proteome profiles by referring to isolated primary cells.
Wimmer H; Gundacker NC; Griss J; Haudek VJ; Stättner S; Mohr T; Zwickl H; Paulitschke V; Baron DM; Trittner W; Kubicek M; Bayer E; Slany A; Gerner C
Electrophoresis; 2009 Jun; 30(12):2076-89. PubMed ID: 19582709
[TBL] [Abstract][Full Text] [Related]
11. What does it need to be a biomarker? Relationships between resolution, differential quantification and statistical validation of protein surrogate biomarkers.
Schrattenholz A; Groebe K
Electrophoresis; 2007 Jun; 28(12):1970-9. PubMed ID: 17516580
[TBL] [Abstract][Full Text] [Related]
12. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
Lee JW; Figeys D; Vasilescu J
Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
[TBL] [Abstract][Full Text] [Related]
13. Application of a peptide-based PF2D platform for quantitative proteomics in disease biomarker discovery.
Lee HJ; Kang MJ; Lee EY; Cho SY; Kim H; Paik YK
Proteomics; 2008 Aug; 8(16):3371-81. PubMed ID: 18651672
[TBL] [Abstract][Full Text] [Related]
14. Empowering spot detection in 2DE images by wavelet denoising.
Soggiu A; Marullo O; Roncada P; Capobianco E
In Silico Biol; 2009; 9(3):125-33. PubMed ID: 19795570
[TBL] [Abstract][Full Text] [Related]
15. Capillary separations enabling tissue proteomics-based biomarker discovery.
Guo T; Lee CS; Wang W; DeVoe DL; Balgley BM
Electrophoresis; 2006 Sep; 27(18):3523-32. PubMed ID: 16977682
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular proteomics: translational studies to develop novel biomarkers in heart failure and left ventricular remodeling.
Dubois E; Fertin M; Burdese J; Amouyel P; Bauters C; Pinet F
Proteomics Clin Appl; 2011 Feb; 5(1-2):57-66. PubMed ID: 21246740
[TBL] [Abstract][Full Text] [Related]
17. Depletion of high-abundance proteins in plasma by immunoaffinity subtraction for two-dimensional difference gel electrophoresis analysis.
Dardé VM; Barderas MG; Vivanco F
Methods Mol Biol; 2007; 357():351-64. PubMed ID: 17172701
[TBL] [Abstract][Full Text] [Related]
18. Plasma proteomics: a noninvasive window on pathology and pediatric cardiac surgery.
Lull ME; Freeman WM; Myers JL; Midgley F; Kimatian SJ; Undar A; Vrana KE
ASAIO J; 2006; 52(5):562-6. PubMed ID: 16966860
[TBL] [Abstract][Full Text] [Related]
19. Clinical proteomics and biomarker discovery.
Johann DJ; McGuigan MD; Patel AR; Tomov S; Ross S; Conrads TP; Veenstra TD; Fishman DA; Whiteley GR; Petricoin EF; Liotta LA
Ann N Y Acad Sci; 2004 Jun; 1022():295-305. PubMed ID: 15251975
[TBL] [Abstract][Full Text] [Related]
20. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics.
Lee HJ; Lee EY; Kwon MS; Paik YK
Curr Opin Chem Biol; 2006 Feb; 10(1):42-9. PubMed ID: 16418010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
